Botox® rival Reloxin® could go on sale in U.S. next year
Botox® challenger Reloxin® could reach the U.S. marketplace next year.
Its corporate sponsors, Medicis® Pharmaceutical of Scottsdale, Ariz., and Ipsen filled their application for Food and Drug Administratin.
Medicis said it is hoping for FDA action on the application by early 2009.
Ipsen makes the drug, a dilute form of botulinum toxin similar to Botox, and sells it in about 20 countries under the name Dysport. If the two companies win FDA clearance, Medicis would market it in the United States under the name Reloxin.
Botox, made by Irvine-based Allergan®, is the No. 1 cosmetic medical treatment in the United States, with more than 3 million injections in 2006, according to the American Society for Aesthetic Plastic Surgery. Medicis estimated that the U.S. market for cosmetic botulinum toxin injections totals $300 million to $400 million.
Our Practice has been the #1 Botox® provider in the entire San Diego County. And our physicians have trained many other physicians in the use of Botox.
As our commitment to our patient we will also try to be at the forefront when Reloxin® enters the market.
Amir Moradi, M.D.
AM/mm
Its corporate sponsors, Medicis® Pharmaceutical of Scottsdale, Ariz., and Ipsen filled their application for Food and Drug Administratin.
Medicis said it is hoping for FDA action on the application by early 2009.
Ipsen makes the drug, a dilute form of botulinum toxin similar to Botox, and sells it in about 20 countries under the name Dysport. If the two companies win FDA clearance, Medicis would market it in the United States under the name Reloxin.
Botox, made by Irvine-based Allergan®, is the No. 1 cosmetic medical treatment in the United States, with more than 3 million injections in 2006, according to the American Society for Aesthetic Plastic Surgery. Medicis estimated that the U.S. market for cosmetic botulinum toxin injections totals $300 million to $400 million.
Our Practice has been the #1 Botox® provider in the entire San Diego County. And our physicians have trained many other physicians in the use of Botox.
As our commitment to our patient we will also try to be at the forefront when Reloxin® enters the market.
Amir Moradi, M.D.
AM/mm
posted by Face Beautiful at
4:12 PM
<< Home